The EMPA-KIDNEY Collaborative Group
The research on GLP-1s impact on addictive behaviors creates new treatment possibilities for patients facing substance use challenges alongside weight concerns
The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities for better health for our patients with obesity and diabetes, said Deborah Horn, DO, MPH, professor and director of obesity medicine at McGovern Medical School at UTHealth Houston and principal author of the study
Through Klinic, you'll complete a comprehensive medical intake form, be evaluated by a licensed provider specializing in weight management, and, if appropriate, receive a prescription for weight loss medication as part of your personalized treatment plan
Our guide on what to do when tirzepatide seems to stop working addresses the plateau periods that are common during treatment